Globus Medical, Inc. Class A Common Stock (GMED)

Cost of Revenue

$241.44M

Quarterly · Period ending: · USD

GMED logo

GMED Cost of Revenue

Latest reported$241.44M
GMED Quarterly Cost of Revenue ($14.90M → $241.44M)
High-resolution chart · PNG

GMED cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Globus Medical, Inc. Class A Common Stock Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
241,439,000
234,066,000
231,262,000
282,376,000
248,765,000
195,397,000
263,437,000
270,515,000
260,040,000
241,487,000
265,486,000
135,390,000
76,473,000
70,825,000
70,591,000
65,497,000
68,470,000
59,167,000
61,796,000
58,554,000
63,846,000
55,027,000
60,859,000
57,097,000
50,643,000
48,864,000
48,761,000
45,387,000
43,990,000
41,838,000
45,954,000
37,849,000
37,637,000
37,970,000
40,856,000
36,798,000
37,199,000
35,600,000
39,002,000
31,453,000
32,731,000
31,519,000
35,065,000
32,927,000
32,579,000
32,107,000
31,276,000
27,686,000
26,583,000
25,312,000
26,774,000
25,315,000
24,761,000
23,493,000
19,557,000
18,872,000
18,379,000
18,391,000
19,487,000
17,141,000
17,269,000
14,899,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.